Creative Medical Technology Holdings has extended the applications of its investigational “regenerative immunotherapy” ImmCelz to include Parkinson’s disease, after seeing positive preclinical data from a mouse model of the disease, according to a company press release. ImmCelz inhibited the onset of Parkinson’s symptoms in a mouse model of the…
The Parkinson’s Foundation has received a $30,000 grant from the National Endowment for the Arts (NEA) to support a photo exhibition by Los Angeles-based artist Safi Alia Shabaik documenting her father’s journey with Parkinson’s disease. “I am humbled and elated by the NEA’s thoughtful recognition of this project…
A rapid, inexpensive, and easy-to-use test can help to assess a loss of smell, and with greater accuracy than current “scratch and sniff” tests, allowing neurological disorders like Parkinson’s disease to be suspected at early stages, researchers report. Their study “A novel capsule-based smell test fabricated via coaxial…
Motor deficits, including problems with balance skills and gait or walking speed, are linked with non-motor symptoms of cognition — such as verbal fluency, memory, and attention — in people with Parkinson’s disease, a recent study suggests. Researchers believe these findings may help to identify cognitive deficits and…
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, held April 17–22. Go here to read stories from the conference. Deep brain stimulation (DBS) can lessen motor function impairments and reduce the need for medication for up to 10 years in…
People with Parkinson’s disease have an altered perception of movement when viewing abstract art as compared with their age- and education-matched healthy peers, a study found. These results suggest that motor responses, aesthetic appreciation, and motion are somehow linked — and that altered neurological function, such as that observed…
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. People with Parkinson’s disease are using more cannabis-based products, especially those containing cannabidiol (CBD), as a treatment option to ease…
The nonprofit Parkinson Canada has teamed up with technology company Catalyst to enhance awareness of available digital health tools that can help people with Parkinson’s disease keep up their medication regimen. People diagnosed with Parkinson’s usually require treatment with multiple medications, often with frequent dosing, to adequately…
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Carbidopa/levodopa enteral suspension (CLES) provided long-term, sustained, and clinically meaningful reductions in “off” time for people with Parkinson’s disease, according…
PhotoPharmics plans to open, possibly this summer, a pivotal Phase 3 clinical trial of its light-based and noninvasive Celeste device in treating Parkinson’s symptoms, for use by patients at home and with trial goals evaluated using telemedicine. A particular company goal for this device, PhotoPharmics also announced, is reaching underserved patients…
Get regular updates to your inbox.
